Through biopharmaceutical research and development,
we will help humanity and medicine to advance.

In an effort to make sure our R&D meets future standards, Yoshindo is currently working on several biopharmaceutical projects. One of these projects is the commissioned manufacture of biopharmaceuticals. This project has led to us embarking on ground-breaking biopharmaceutical work—not something commonly done by generic drug company. Additionally, the joint venture we formed with Lupin Limited (India): YL Biologics have been working on the development of a biosimilar for the rheumatoid arthritis drug “Enbrel”. They aim to sell the drug in Japan once their work is complete.